issue

Sep 20, 2019

Volume 15 Number 7

This edition presents a novel method to assess strain and mechanical stress applied to bioprosthetic valve leaflets during the cardiac cycle; a look at the haemodynamic implications of primary implantation of an IABP versus inotropes for decompensated heart failure and low output; a study of MLA relocation after BRS or metallic stent implantation; from the AIDA trial, a comparison of everolimus-eluting BRS with an everolimus-eluting metallic stent and the MeRes-1 trial, studying outcomes of a thin-strut sirolimus-eluting bioresorbable vascular scaffold.

Editorial

Antithrombotic therapy after TAVI: where are we going?
Wilkins B, Fukutomi M, Søndergaard L
10.4244/EIJV15I7A102
free
Mitral valve regurgitation: a plea for transcatheter mitral valve replacement
Modine T, Prendergast B, Piazza N, Overtchouk P
10.4244/EIJV15I7A103
free
Sex differences in clinical outcomes following bioresorbable scaffold implantation: a paradigm shift?
Bourantas C, Bajaj R, Tufaro V, Kilic Y, Serruys PW
10.4244/EIJV15I7A105
free

Interventions for valvular disease and heart failure

A novel method to quantitate bioprosthetic valve leaflet mechanical stress: a numerical and in vitro study
Stanová V, Godio Raboutet Y, Masson C, Py M, Barragan P, Thollon L, Rieu R, Pibarot P
10.4244/EIJ-D-19-00327
free
Primary intra-aortic balloon support versus inotropes for decompensated heart failure and low output: a randomised trial
den Uil C, Van Mieghem NM, Bastos M, Jewbali L, Lenzen M, Engstrom A, Bunge J, Brugts J, Manintveld O, Daemen J, Wilschut J, Zijlstra F, Constantinescu A
10.4244/EIJ-D-19-00254
free

Coronary interventions

Acute and long-term relocation of minimal lumen area after bioresorbable scaffold or metallic stent implantation
Katagiri Y, Serruys PW, Tenekecioglu E, Asano T, Collet C, Miyazaki Y, Katsikis A, Piek J, Wykrzykowska JJ, Chevalier B, Mintz GS, Stone GW, Onuma Y
10.4244/EIJ-D-18-00422
free
Comparison of an everolimus-eluting bioresorbable scaffold with an everolimus-eluting metallic stent in routine PCI: three-year clinical outcomes from the AIDA trial
Kerkmeijer L, Tijssen R, Hofma S, van der Schaaf R, Arkenbout KE, Kraak R, Weevers A, Piek J, de Winter R, Tijssen J, Henriques J, Wykrzykowska JJ, Ijsselmuiden A, Kauer F, Beijk M, Vis MM, Koch K
10.4244/EIJ-D-19-00325
free
Three-year clinical and two-year multimodality imaging outcomes of a thin-strut sirolimus-eluting bioresorbable vascular scaffold: MeRes-1 trial
Seth A, Onuma Y, Chandra P, Bahl V, Manjunath C, Mahajan A, Kumar V, Goel P, Wander G, Kaul U, Ajit Kumar V, Abizaid A, Serruys PW
10.4244/EIJ-D-19-00324
free
Sex and long-term outcomes after implantation of the Absorb bioresorbable vascular scaffold for treatment of coronary artery disease
Baquet M, Hoppmann P, Grundmann D, Schmidt W, Kufner S, Theiss H, Brunner S, Wiebe J, Eickhoff M, Jochheim D, Byrne RA, Laugwitz K, Schunkert H, Massberg S, Kastrati A, Mehilli J
10.4244/EIJ-D-18-00603
free
Predictors of long-term adverse events after Absorb bioresorbable vascular scaffold implantation: a 1,933-patient pooled analysis from international registries
Caixeta A, Campos C, Felix C, Chieffo A, Capranzano P, Kawamoto H, Tamburino C, Diletti R, Costa Jr J, Onuma Y, van Geuns R, Bartorelli AL, Colombo A, Tamburino C, Serruys PW, Abizaid A
10.4244/EIJ-D-16-00796
free
Impact of the one-year angioscopic findings on long-term clinical events in 504 patients treated with first-generation or second-generation drug-eluting stents: the DESNOTE-X study
Sotomi Y, Suzuki S, Kobayashi T, Hamanaka Y, Nakatani S, Hirata A, Takeda Y, Ueda Y, Sakata Y, Higuchi Y
10.4244/EIJ-D-18-00660
free
Bioresorbable magnesium scaffold in complex PCI in a nickel allergy patient: one-year follow-up – no disease, no scaffolds
Bayón J, Santás-Álvarez M, Ocaranza-Sánchez R, González-Juanatey C
10.4244/EIJ-D-18-00400
free
Double-layer bare metal stents in the treatment of coronary artery aneurysm: experience and outcomes in nine patients
Qiao S, Xiaowei J, Cui J, Li J, Yuan J, Liu S, Gao L, Zhao J, Chen H, Ma J
10.4244/EIJ-D-18-01093
free

Receive our newsletter

The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

EuroPCR EAPCI
PCR ESC
Impact factor: 7.6
2023 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2024)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2024 Europa Group - All rights reserved